World's Best Scientists 2026 revealed!
Raymond F. Schinazi

Raymond F. Schinazi

D-Index & Metrics

Medicine

D-Index
106
Citations
45407
World Ranking
6479
National Ranking
3446

Research.com Recognitions

  • 2020 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2012 - Fellow, National Academy of Inventors

Overview

Raymond F. Schinazi is affiliated with Emory University in the United States and has an extensive research portfolio primarily in the field of Medicine. Their work spans multiple subfields, including Infectious Diseases, Epidemiology, Molecular Biology, Virology, and Hepatology.

The scientist's research topics cover a range of areas with notable emphasis on:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • Hepatitis B Virus Studies
  • SARS-CoV-2 detection and testing

Some of the recent papers authored or co-authored by Raymond F. Schinazi include:

  • COVID-19: Discovery, diagnostics and drug development, 2020, Journal of Hepatology
  • Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template, 2021, Journal of Biological Chemistry
  • β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells, 2021, The Journal of Infectious Diseases
  • Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques, 2020, Cell
  • Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020, Emerging infectious diseases

Frequent co-authors who have collaborated with Schinazi include:

  • Leda Bassit
  • Franck Amblard
  • Baek Kim
  • Sijia Tao
  • Keivan Zandi

Schinazi's work appears frequently in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Biological Chemistry
  • Viruses
  • Molecules
  • UNC Libraries

Notable recognitions awarded to Raymond F. Schinazi include:

  • Fellow of the American Association for the Advancement of Science (AAAS), 2020
  • Fellow, National Academy of Inventors, 2012

Best Publications

  • Polyoxometalates in Medicine

    Jeffrey T. Rhule;Craig L. Hill;Deborah A. Judd;Raymond F. Schinazi

  • A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

    Lieven Stuyver;Sija De Gendt;Caroline Van Geyt;Fabien Zoulim

  • Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.

    Shin-Lian Doong;Ching-Hwa Tsai;Raymond F. Schinazi;Dennis C. Liotta

  • Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region

    Lieven J. Stuyver;Stephen A. Locarnini;Anna Lok;Douglas D. Richman

  • Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs

    Ugo Pradere;Ethel C. Garnier-Amblard;Steven J. Coats;Franck Amblard

  • Zika Virus Infects Human Placental Macrophages

    Kendra M. Quicke;Kendra M. Quicke;James R. Bowen;James R. Bowen;Erica L. Johnson;Circe E. McDonald;Circe E. McDonald

  • Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.

    R F Schinazi;A McMillan;D Cannon;R Mathis

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

    J. Gerardo García-Lerma;Ron A. Otten;Shoukat H. Qari;Eddie Jackson

  • Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.

    R F Schinazi;R M Lloyd;M H Nguyen;D L Cannon

  • COVID-19: Discovery, diagnostics and drug development.

    Tarik Asselah;David Durantel;Eric Pasmant;George Lau

  • The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance.

    Suzane Kioko Ono;Naoya Kato;Yasushi Shiratori;Jun Kato

  • Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes.

    R F Schinazi;C K Chu;A Peck;A McMillan

  • Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.

    Lin Tai-Shun;Raymond F. Schinazi;William H. Prusoff

  • In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora

    Yuh-Meei Lin;Herbert Anderson;Michael T. Flavin;Yeah-Huei S. Pai

  • Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs

    Jadd Shelton;Xiao Lu;Joseph A. Hollenbaugh;Jong Hyun Cho

  • Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene.

    R. F. Schinazi;Rint Sijbesma;G. Srdanov;C. L. Hill

  • Design, Synthesis, and Antiviral Activity of 2‘-Deoxy-2‘-fluoro-2‘-C-methylcytidine, a Potent Inhibitor of Hepatitis C Virus Replication

    Jeremy L. Clark;Laurent Hollecker;J. Christian Mason;Lieven J. Stuyver

  • Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

    Mirjam B. Zeisel;Julie Lucifora;William S. Mason;Camille Sureau

  • HCV direct‐acting antiviral agents: the best interferon‐free combinations

    Raymond Schinazi;Philippe Halfon;Patrick Marcellin;Tarik Asselah

Frequent Co-Authors

Chung K. Chu
Chung K. Chu University of Georgia
Dennis C. Liotta
Dennis C. Liotta Emory University
Baek Kim
Baek Kim Emory University
Craig L. Hill
Craig L. Hill Emory University
Yung-Chi Cheng
Yung-Chi Cheng Yale University
William H. Prusoff
William H. Prusoff Yale University
Harold M. McClure
Harold M. McClure Emory University
Brent E. Korba
Brent E. Korba Georgetown University
Bud C. Tennant
Bud C. Tennant Cornell University
Jacob D. Estes
Jacob D. Estes Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional MD in the USA is just one route into the healthcare field. Today, many students are exploring flexible, affordable online programs that unlock a variety of rewarding career pathways. For example, the demand for pharmacists continues to grow, with online pharmd programs offering a convenient way to earn a Doctor of Pharmacy degree without relocating.

Those interested in the evolving world of digital health can consider accredited him programs focused on health information management, leading to in-demand roles managing health data and electronic records.

Alternatively, if you're looking for a quick entry point into healthcare administration, there are low cost medical coding and billing online program options that typically require less time and investment than traditional degrees.

For those drawn to direct patient care but unsure about medical school, consider the cheapest nurse practitioner programs online, which prepare graduates for advanced practice roles with a focus on accessibility and value.

Each of these online programs offers a flexible, cost-effective pathway into a vital area of healthcare—helping you shape your own unique career journey.

Best Scientists Citing Raymond F. Schinazi

Trending Scientists